BIOSK — Unibios Holdings SA Cashflow Statement
0.000.00%
Last trade - 00:00- €51.69m
- €53.21m
- €14.72m
- 70
- 34
- 90
- 76
Annual cashflow statement for Unibios Holdings SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.041 | 0.552 | 0.998 | 2.4 | 1.55 |
| Depreciation | |||||
| Non-Cash Items | 0.341 | 0.141 | 0.272 | -0.675 | 0.566 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.85 | 0.002 | -3.68 | -1.25 | -2.41 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.087 | 1.06 | -1.98 | 0.869 | 0.149 |
| Capital Expenditures | -0.063 | -0.055 | -0.394 | -0.223 | -0.875 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.003 | -0.011 | -0.037 | 4.15 | -0.065 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.065 | -0.066 | -0.43 | 3.92 | -0.94 |
| Financing Cash Flow Items | 0.678 | 0.022 | -0.251 | 0.003 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.15 | -0.877 | 1.37 | -2.06 | 0.856 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1 | 0.117 | -1.04 | 2.74 | 0.065 |